Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP113517.RAtBVNnlYl4e0UpC7NhBJXtQdMXPl6soiqJ6UfiNvxUXw130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP113517.RAtBVNnlYl4e0UpC7NhBJXtQdMXPl6soiqJ6UfiNvxUXw130_provenance.
• NP113538.RAAHJeha-YaReKjT0tt_IzKn_YrQYW4IMQ-uUoUe8Z_tc130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP113538.RAAHJeha-YaReKjT0tt_IzKn_YrQYW4IMQ-uUoUe8Z_tc130_provenance.
• NP180399.RAegGDPKr-yqSTIBZnTOgB__yfGGlu0drShwvBPiJDz38130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180399.RAegGDPKr-yqSTIBZnTOgB__yfGGlu0drShwvBPiJDz38130_provenance.
• assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
• NP180398.RAv4uhUFHC8oQfvRLMOqY1BHgtLrBPGf11YgSu81Av1sk130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180398.RAv4uhUFHC8oQfvRLMOqY1BHgtLrBPGf11YgSu81Av1sk130_provenance.
• NP111750.RAx_PtQT6PiTGuKVhCbDaeqhjzT6ugokFr0HoYv6NjBlA130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111750.RAx_PtQT6PiTGuKVhCbDaeqhjzT6ugokFr0HoYv6NjBlA130_provenance.
• NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_provenance.
• NP113531.RA4jE5FnDFDryzOMbDr8ENxUk95oJIp3vGkCaN91YnqLw130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP113531.RA4jE5FnDFDryzOMbDr8ENxUk95oJIp3vGkCaN91YnqLw130_provenance.
• NP142527.RA0h9fP2YlYo2ll5P7LrUZOZg1ByWvjGZp6_1dpOtXKYQ130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP142527.RA0h9fP2YlYo2ll5P7LrUZOZg1ByWvjGZp6_1dpOtXKYQ130_provenance.
• NP143266.RA5-E0swquYULKXzTRH_qwwqL-lSUVBLirqywElvr1eUQ130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143266.RA5-E0swquYULKXzTRH_qwwqL-lSUVBLirqywElvr1eUQ130_provenance.
• NP111740.RAJ3tD6MbpfC1gOCTXxQFCvbJADM3DpCGyzqBH3ZaHdeU130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111740.RAJ3tD6MbpfC1gOCTXxQFCvbJADM3DpCGyzqBH3ZaHdeU130_provenance.
• NP180400.RALwKFFJI3Kve4MVTlK0KYy_DVH9qGt8lt0bSxvCANA3Y130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180400.RALwKFFJI3Kve4MVTlK0KYy_DVH9qGt8lt0bSxvCANA3Y130_provenance.
• NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_provenance.
• NP180397.RAxD12PZDEHq-kaXm40X9uXkTz3uobXMvQnEJcQj9v2mQ130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180397.RAxD12PZDEHq-kaXm40X9uXkTz3uobXMvQnEJcQj9v2mQ130_provenance.